DM
Devalben Miteshbhai Bhavsar
About Devalben Miteshbhai Bhavsar
Data last updated:
Devalben Miteshbhai Bhavsar is a Whole-Time Director at Saurashtra Medisolutions Private Limited (since 2022). The company operates in Pharma. Saurashtra Medisolutions Private Limited reported revenue of ₹48.89 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saurashtra Medisolutions Private Limited U24304GJ2022PTC128793 | Whole-Time Director | 21 Jan 2022 | 2022 | ₹48.89 Cr (FY 2025) | Active |
Board colleagues of Devalben Miteshbhai Bhavsar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gaurav Kumar | 09693244 | Saurashtra Medisolutions Private Limited | Director |
| Manish Kumar | 11135203 | Saurashtra Medisolutions Private Limited | Director |
| Mitesh Bansilal Bhavsar | 09477216 | Saurashtra Medisolutions Private Limited | Whole-Time Director |
| Sharad Jaiswal | 10227043 | Saurashtra Medisolutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devalben Miteshbhai Bhavsar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devalben Miteshbhai Bhavsar
Devalben Miteshbhai Bhavsar currently holds 1 directorship: Saurashtra Medisolutions Private Limited (Whole-Time Director, since 21 Jan 2022, revenue ₹48.89 Cr (FY 2025)).
Devalben Miteshbhai Bhavsar was first appointed on 21 Jan 2022 as Whole-Time Director at Saurashtra Medisolutions Private Limited.
The current boards of Devalben Miteshbhai Bhavsar's companies include Gaurav Kumar (Saurashtra Medisolutions Private Limited), Manish Kumar (Saurashtra Medisolutions Private Limited), Mitesh Bansilal Bhavsar (Saurashtra Medisolutions Private Limited), Sharad Jaiswal (Saurashtra Medisolutions Private Limited).